QuidelOrtho director awarded 1,252 shares in RSU release

QuidelOrtho Corp director Michael Edward L. reported compensation-related equity activity.

Rhea-AI Filing Summary

QuidelOrtho Corp director Michael Edward L. reported compensation-related equity activity. He received 1,252 shares of common stock through the release and conversion of restricted stock units on June 6, 2026, at a stated price of $0.00 per share as part of his director compensation. Following these awards and conversions, he holds approximately 29,433 common shares directly. Footnotes explain the restricted stock units were previously reported, each unit represents one common share, and their release was deferred under QuidelOrtho’s deferred compensation program for participating non-employee directors.

Insider Trade Summary

1,252 shares exercised/converted

Exercise 4 txns

Insider Michael Edward L.

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units (Converted)	963	$0.00	$0.00
Exercise	Restricted Stock Units (Premium)	289	$0.00	$0.00
Grant/Award	Common Stock	963	$0.00	$0.00
Grant/Award	Common Stock	289	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units (Converted) — 0 contracts (Direct); Restricted Stock Units (Premium) — 0 contracts (Direct); Common Stock — 29,433 shares (Direct)

Footnotes (3)

1. F1. Reflects release of restricted stock units that were previously reported on a Form 4.
2. F2. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
3. F3. Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.

Key Figures

Common shares from RSU release: 1,252 shares Award tranche 1: 289 shares Award tranche 2: 963 shares +3 more

6 metrics

Common shares from RSU release 1,252 shares Restricted stock units converted to common stock on June 6, 2026

Award tranche 1 289 shares Common stock acquired from RSU release on June 6, 2026

Award tranche 2 963 shares Common stock acquired from RSU release on June 6, 2026

Post-transaction holdings 29,433 shares Common stock directly held after June 6, 2026 transactions

Exercise price per share $0.00 per share Stated price for common stock received from RSU conversions

Derivative exercises 1,252 shares Total restricted stock units exercised/converted

Key Terms

restricted stock units, derivative security, deferred compensation program, non-employee directors

4 terms

restricted stock units financial

"Reflects release of restricted stock units that were previously reported on a Form 4."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

derivative security financial

"Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

deferred compensation program financial

"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors"

non-employee directors financial

"deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule"

Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did QuidelOrtho Corp (QDEL) report for Michael Edward L.?

QuidelOrtho Corp reported that director Michael Edward L. acquired 1,252 shares of common stock on June 6, 2026. These shares came from the release and conversion of previously granted restricted stock units as part of his non-employee director compensation.

Were the QuidelOrtho (QDEL) insider transactions open-market purchases or sales?

The reported QuidelOrtho transactions were not open-market trades. They reflect the release and conversion of restricted stock units into common shares at a stated price of $0.00 per share, consistent with stock-based compensation for a non-employee director.

How many QuidelOrtho (QDEL) shares does Michael Edward L. hold after these transactions?

After the June 6, 2026 activity, Michael Edward L. directly holds approximately 29,433 shares of QuidelOrtho common stock. This position reflects stock-based compensation awards and the settlement of restricted stock units previously reported on earlier Forms 4.

What do the restricted stock unit footnotes mean in the QuidelOrtho (QDEL) Form 4?

The footnotes explain that each restricted stock unit equals one common share of QuidelOrtho and that the units were previously reported. Their release was deferred under QuidelOrtho’s deferred compensation program for participating non-employee directors, following the director’s elected schedule.

Does the QuidelOrtho (QDEL) Form 4 show any stock option exercises or remaining derivatives?

The Form 4 shows the exercise/conversion of restricted stock units into common shares, coded as derivative transactions. The derivative summary is empty afterward, indicating no remaining restricted stock units related to these specific awards are shown in this filing excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/09/2026 - 04:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Michael Edward L.

(Last) (First) (Middle)

9975 SUMMERS RIDGE ROAD

(Street)

SAN DIEGO CALIFORNIA 92121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/06/2026		A		963(1)	A	$0	29,144	D
Common Stock	06/06/2026		A		289(1)	A	$0	29,433	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (Converted)	(2)	06/06/2026		M			963	(3)	(3)	Common Stock	963	$0	0	D
Restricted Stock Units (Premium)	(2)	06/06/2026		M			289	(3)	(3)	Common Stock	289	$0	0	D

Explanation of Responses:

1. Reflects release of restricted stock units that were previously reported on a Form 4.

2. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

3. Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.

Remarks:

	/s/ Phillip S. Askim, attorney-in-fact for Edward L. Michael	06/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)